Goto

Collaborating Authors

banking & finance


Carrot and Luxboro Launch IoT Joint Venture - PR Newswire APAC

#artificialintelligence

Carrot ("Carrot" or the "Company") and Luxrobo announced today the establishment of a Joint Venture (JV) that brings together two premier tech companies from the field of digital insurance and IoT-technology. Together they operate as Lucky Box Solutions Inc. to deliver the most optimized IoT systems and telematics devices while positioning itself as the leader of InsurTech, industry that has become the noise of the town in recent years. Both companies have established proven track records of providing innovation in emerging sectors and are poised to offer cutting-edge solutions in the areas of Artificial Intelligence, Machine Learning, Data Interoperability, Analytics and Processing, and Internet of Things while providing risk prevention and insurance protection services. Carrot has made a name for itself over the past few years by providing modernized insurance service to the consumers of South Korea with its customer-centered design of Pay-Per-Mile auto insurance product. As seen with its top-tier customer retention, customers are highly praising for its fair and transparent pricing, month-end payment term, IoT-driven emergency and other value-added services, and cash incentive program that rewards customers based on their safe-driving scores.


1 Artificial Intelligence Growth Stock to Buy Right Now

#artificialintelligence

The stock market is currently on the roughest losing streak since the start of the pandemic in 2020. The broad S&P 500 index is down 19% from its all-time high, putting it within a whisker of bear market territory. But the tech-centric Nasdaq-100 index is already there, with a loss of 28.3% since November 2021. While the investment picture might be nerve-wracking for many investors, history suggests down markets always eventually recover, so this might actually be a great time to put some money to work. Here's one fast-growing stock leveraging advanced technology, and it's worth considering because it's trading at an 88.9% discount to its all-time high, despite the company being highly profitable.


Preparing for quantum: next steps for enterprise

#artificialintelligence

Investment in quantum technologies will grow from US$412mn in 2020 to US$8.6bn by 2027, according to research firm IDC. Organisations that get started now will have a significant competitive advantage over those that continue to wait until quantum computing is a proven technology. Nevertheless, the complexity of quantum hardware and software development are forcing organisations to invest significantly in elite quantum expertise just to explore quantum-possible use cases for their potential business value. Gordon Davey is Cloud Services (Microsoft) General Manager at SoftwareONE, a leading global provider of end-to-end software and cloud technology solutions. Davey said: "Quantum technologies within enterprises are expected to take off over the next five years, with forecasts estimating that the market will eventually be worth anywhere between $500mn to $29bn, according to IBM. The development of quantum computing is speeding up, and technology firms are partnering up with businesses to work on bringing out the first commercial applications. A great example of this is Goldman Sachs, who recently assembled a'full team dedicated to quantum computing', and JP Morgan, who is now looking to implement the use of quantum computers as well. Additionally, Willis Tower Watson has also partnered up with Microsoft to develop the potential of quantum computing."


Artificial Intelligence: The Science Behind The Good Customer Experience - Elets BFSI

#artificialintelligence

Artificial Intelligence (AI), as one of the leading technological trends, continues to grow in popularity among marketers and sales professionals, and has evolved into an essential tool for brands seeking to provide a hyper-personalized, exceptional customer experience. AI-enhanced customer relationship management (CRM) and customer data platform (CDP) software is now available, bringing AI to the enterprise without the high costs previously associated with the technology. On the basis of exclusive interactions with leaders in the BFSI sector, Nidhi Shail Kujur of Elets News Network (ENN) explores how with constantly evolving technologies, the banking and financial services industry promises to exceed customer expectations. The banking industry is undergoing significant change, particularly with the spread of customer-centricity. We live in a world where the majority of people have access to the internet.


ISO/IEC AI workshop - JTC 1

#artificialintelligence

Babak Hodjat is the CTO for AI at Cognizant where he leads a team of developers and researchers bringing advanced AI solutions to businesses. Babak is the former co-founder and CEO of Sentient, responsible for the core technology behind the world's largest distributed artificial intelligence system. Babak was also the founder of the world's first AI-driven hedge-fund, Sentient Investment Management. Babak is a serial entrepreneur, having started a number of Silicon Valley companies as main inventor and technologist. Prior to co-founding Sentient, Babak was senior director of engineering at Sybase iAnywhere, where he led mobile solutions engineering.


Can an artificial intelligence bot make a 1% daily profit in cryptocurrency?

#artificialintelligence

I've been watching this trade pop up all over my newsfeed and I am so intrigued. I have a background in computer science and programming and I know enough to be dangerous, but this seems like it would take some serious skill. So what is the deal with automated trading bots? How can a bot make 1% daily profit? This post will answer all of your questions about automating cryptocurrency trading with artificial intelligence (AI) bots.


Conversational AI Platform as Digital Fabric for Banks - Elets BFSI

#artificialintelligence

Conversational AI is a type of artificial intelligence that facilitates the human like conversation between a human and a software system in real time. It is a piece of software that a person can talk to, like chatbot, social messaging app, interactive agent, or smart device. These applications enable users to ask questions, get opinions, find support, or complete tasks remotely. Conversational systems are powered by a conversational engine named NLP (Natural Language Processing, a branch of AI that deals with linguistic and conversational cognitive science). They make use of large volumes of data processed with machine learning, and natural language processing to aid imitate human interactions, recognizing speech and text inputs and translating their meanings in different languages. Businesses can setup automated chatbots or virtual assistants that can communicate with humans via voice or text and in different languages of user preferences.


Will Artificial Intelligence and robotics usher in an era of sustainable precision agriculture?

#artificialintelligence

Across midwestern farms, if Girish Chowdhary has his way, farmers will someday release beagle-sized robots into their fields like a pack of hounds flushing pheasant. The robots, he says, will scurry in the cool shade beneath a wide diversity of plants, pulling weeds, planting cover crops, diagnosing plant infections, and gathering data to help farmers optimize their farms. Chowdhary, a researcher at the University of Illinois, works surrounded by corn, one of the most productive monocultures in the world. In the United States, the corn industry was valued at $82.6 billion in 2021, but it -- like almost every other segment of the agricultural economy -- faces daunting problems, including changing weather patterns, environmental degradation, severe labor shortages, and the rising cost of key supplies, or inputs: herbicides, pesticides, and seed. Agribusiness as a whole is betting that the world has reached the tipping point where desperate need caused by a growing population, the economic realities of conventional farming, and advancing technology converge to require something called precision agriculture, which aims to minimize inputs and the costs and environmental problems that go with them. No segment of agriculture is without its passionate advocates of robotics and artificial intelligence as solutions to, basically, all the problems facing farmers today.


C3.ai Stock: Meteoric Growth With AI Tailwinds (NYSE:AI)

#artificialintelligence

C3.ai (NYSE:AI) is a leading software company, which provides Artificial Intelligence services to enterprises. The company is poised to ride the wave of growth forecasted for AI. The global Artificial Intelligence (AI) market is forecasted to grow at a meteoric 20.1% CAGR from $387 billion in 2022 to over $1.3 trillion by 2029. C3.ai serves an envious list of large reputable customers from The US Air Force and the Department of Defence, to large energy companies such as Shell & Engie. They have been growing revenues at a 40% CAGR over the past couple of years, while the stock price has declined massively.


Artificial intelligence makes a splash in small-molecule drug discovery

#artificialintelligence

In the past five years, interest in applying artificial intelligence (AI) approaches in drug research and development (R&D) has surged. Driven by the expectation of accelerated timelines, reduced costs and the potential to reveal hidden insights from vast datasets, more than 150 companies with a focus on AI have raised funding in this period, based on an analysis of the field by Back Bay Life Science Advisors (Figure 1a). And the number of financings and average amount raised soared in 2021. At the forefront of this field are companies harnessing AI approaches such as machine learning (ML) in small-molecule drug discovery, which account for the majority of financings backed by venture capital (VC) in recent years (Figure 1b), as well as some initial public offerings (IPOs) for pioneers in the area (Table 1). Such companies have also attracted large pharma companies to establish multiple high-value partnerships (Table 2), and the first AI-based small-molecule drug candidates are now in clinical trials (Nat.